Renal tubulointerstitial hypoxia: Cause and consequence of kidney dysfunction

Clinical and Experimental Pharmacology and Physiology

Volumn 38, Issue 7, 2011, Pages 474-480

  Palm, Fredrik ^a,b   Nordquist, Lina ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

Fibrosis; Oxidative stress; Oxygen consumption; Tubulointerstitial hypoxia

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN II; COLLAGEN TYPE 1; CYTOKINE; HEME OXYGENASE; HYPOXIA INDUCIBLE FACTOR; OXYGEN; PHOSPHOLIPASE A2; TRANSFORMING GROWTH FACTOR; VASCULOTROPIN;

CELL INFILTRATION; CELL MATURATION; DISEASE EXACERBATION; EPITHELIAL MESENCHYMAL TRANSITION; FIBROGENESIS; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOCOMPETENT CELL; KIDNEY BLOOD FLOW; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; KIDNEY ISCHEMIA; KIDNEY PERFUSION; KIDNEY TUBULE; KIDNEY TUBULOINTERSTITIAL HYPOXIA; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONSUMPTION; OXYGEN DIFFUSION; OXYGEN SUPPLY; OXYGEN TENSION; OXYGEN TRANSPORT; REVIEW; SODIUM TRANSPORT;

EID: 79959699693     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2011.05532.x     Document Type: Review

References (72)

1. Deng A, Miracle CM, Suarez JM et al. Oxygen consumption in the kidney: Effects of nitric oxide synthase isoforms and angiotensin II. Kidney Int. 2005; 68: 723-30.
2. Levy MN, Sauceda G. Diffusion of oxygen from arterial to venous segments of renal capillaires. Am. J. Physiol. 1959; 196: 1336-9.
3. Levy MN, Imperial ES. Oxygen shunting in renal cortical and medullary capillaries. Am. J. Physiol. 1961; 200: 159-62.
4. Aukland K, Krog J. Renal oxygen tension. Nature 1960; 188: 671.
5. Brezis M, Heyman SN, Epstein FH. Determinants of intrarenal oxygenation. II. Hemodynamic effects. Am. J. Physiol. 1994; 267: F1063-8.
6. Stillman IE, Brezis M, Heyman SN, Epstein FH, Spokes K, Rosen S. Effects of salt depletion on the kidney: Changes in medullary oxygenation and thick ascending limb size. J. Am. Soc. Nephrol. 1994; 4: 1538-45.
7. 2 delivery. Am. J. Physiol. 1980; 238: F50-9.
8. Chance B. Cellular oxygen requirements. Fed. Proc. 1957; 16: 671-80.
9. 2 delivery to the exposed rat kidney. Am. J. Physiol. 1981; 241: F257-62.
10. Epstein FH, Balaban RS, Ross BD. Redox state of cytochrome aa3 in isolated perfused rat kidney. Am. J. Physiol. 1982; 243: F356-63.
11. Leonhardt KO, Landes RR. Oxygen tension of the urine and renal structures. Preliminary report of clinical findings. N. Engl. J. Med. 1963; 269: 115-21.
12. Brezis M, Rosen S, Silva P, Epstein FH. Renal ischemia: A new perspective. Kidney Int. 1984; 26: 375-83.
13. Evans RG, Eppel GA, Michaels S et al. Multiple mechanisms act to maintain kidney oxygenation during renal ischemia in anesthetized rabbits. Am. J. Physiol. Renal. Physiol. 2010; 298: F1235-43.
14. Brodwall EK, Laake H. The relation between oxygen consumption and transport of sodium in the human kidney. Scand. J. Clin. Lab. Invest. 1964; 16: 281-6.
15. Bleyer AJ, Chen R, D'Agostino RB Jr, Appel RG. Clinical correlates of hypertensive end-stage renal disease. Am. J. Kidney Dis. 1998; 31: 28-34.
16. Rodriguez-Iturbe B, Garcia G. The role of tubulointerstitial inflammation in the progression of chronic renal failure. Nephron Clin. Pract. 2010; 116: C81-8.
17. Risdon RA, Sloper JC, De Wardener HE. Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet 1968; 2: 363-6.
18. Bohle A, Mackensen-Haen S, von Gise H et al. The consequences of tubulo-interstitial changes for renal function in glomerulopathies A morphometric and cytological analysis. Pathol. Res. Pract. 1990; 186: 135-44.
19. Eddy AA. Progression in chronic kidney disease. Adv. Chronic Kidney Dis. 2005; 12: 353-65.
20. Brazy PC, Klotman PE. Increased oxidative metabolism in renal tubules from spontaneously hypertensive rats. Am. J. Physiol. 1989; 257: F818-25.
21. Korner A, Eklof AC, Celsi G, Aperia A. Increased renal metabolism in diabetes. Mechanism and functional implications. Diabetes 1994; 43: 629-33.
22. Palm F, Onozato M, Welch WJ, Wilcox CS. Blood pressure, blood flow, and oxygenation in the clipped kidney of chronic 2-kidney, 1-clip rats: Effects of tempol and angiotensin blockade. Hypertension 2010; 55: 298-304.
23. 2 and renal oxygen usage in the hypertensive rat kidney. Kidney Int. 2001; 59: 230-7.
24. Palm F, Connors SG, Mendonca M, Welch WJ, Wilcox CS. Angiotensin II type 2 receptors and nitric oxide sustain oxygenation in the clipped kidney of early Goldblatt hypertensive rats. Hypertension 2008; 51: 345-51.
25. Welch WJ, Blau J, Xie H, Chabrashvili T, Wilcox CS. Angiotensin-induced defects in renal oxygenation: Role of oxidative stress. Am. J. Physiol. Heart Circ. Physiol. 2005; 288: H22-8.
26. Nangaku M. Hypoxia and tubulointerstitial injury: A final common pathway to end-stage renal failure. Nephron Exp. Nephrol. 2004; 98: E8-12.
27. Nangaku M. Chronic hypoxia and tubulointerstitial injury: A final common pathway to end-stage renal failure. J. Am. Soc. Nephrol. 2006; 17: 17-25.
28. Norman JT, Fine LG. Intrarenal oxygenation in chronic renal failure. Clin. Exp. Pharmacol. Physiol. 2006; 33: 989-96.
29. Bernhardt WM, Wiesener MS, Weidemann A et al. Involvement of hypoxia-inducible transcription factors in polycystic kidney disease. Am. J. Pathol. 2007; 170: 830-42.
30. Rosenberger C, Khamaisi M, Abassi Z et al. Adaptation to hypoxia in the diabetic rat kidney. Kidney Int. 2008; 73: 34-42.
31. Tanaka T, Kato H, Kojima I et al. Hypoxia and expression of hypoxia-inducible factor in the aging kidney. J. Gerontol. A Biol. Sci. Med. Sci. 2006; 61: 795-805.
32. 1 receptors in renal hemodynamics and oxygenation in the postclipped 2K, 1C kidney. Hypertension 2003; 41: 692-6.
33. Shao J, Nangaku M, Miyata T et al. Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Hypertension 2003; 42: 31-8.
34. Palm F, Nangaku M, Fasching A et al. Uremia induces abnormal oxygen consumption in tubules and aggravates chronic hypoxia of the kidney via oxidative stress. Am. J. Physiol. Renal Physiol. 2010; 299: F380-6.
35. Palm F, Cederberg J, Hansell P, Liss P, Carlsson PO. Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension. Diabetologia 2003; 46: 1153-60.
36. Fine LG, Orphanides C, Norman JT. Progressive renal disease: The chronic hypoxia hypothesis. Kidney Int. Suppl. 1998; 65: S74-8.
37. Kang DH, Kanellis J, Hugo C et al. Role of the microvascular endothelium in progressive renal disease. J. Am. Soc. Nephrol. 2002; 13: 806-16.
38. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 1992; 12: 5447-54.
39. Leonard MO, Cottell DC, Godson C, Brady HR, Taylor CT. The role of HIF-1alpha in transcriptional regulation of the proximal tubular epithelial cell response to hypoxia. J. Biol. Chem. 2003; 278: 40296-304.
40. Nangaku M, Eckardt KU. Hypoxia and the HIF system in kidney disease. J. Mol. Med. 2007; 85: 1325-30.
41. Chen HH, Chen TW, Lin H. Pravastatin attenuates carboplatin-induced nephrotoxicity in rodents via peroxisome proliferator-activated receptor alpha-regulated heme oxygenase-1. Mol. Pharmacol. 2010; 78: 36-45.
42. Park SK, Dadak AM, Haase VH, Fontana L, Giaccia AJ, Johnson RS. Hypoxia-induced gene expression occurs solely through the action of hypoxia-inducible factor 1alpha (HIF-1alpha): Role of cytoplasmic trapping of HIF-2alpha. Mol. Cell. Biol. 2003; 23: 4959-71.
43. Cummins EP, Taylor CT. Hypoxia-responsive transcription factors. Pflügers Arch. 2005; 450: 363-71.
44. Ohtomo S, Nangaku M, Izuhara Y, Takizawa S, Strihou CY, Miyata T. Cobalt ameliorates renal injury in an obese, hypertensive type 2 diabetes rat model. Nephrol. Dial. Transplant. 2008; 23: 1166-72.
45. Jayle C, Favreau F, Zhang K et al. Comparison of protective effects of trimetazidine against experimental warm ischemia of different durations: Early and long-term effects in a pig kidney model. Am. J. Physiol. Renal Physiol. 2007; 292: F1082-93.
46. Faleo G, Neto JS, Kohmoto J et al. Carbon monoxide ameliorates renal cold ischemia-reperfusion injury with an upregulation of vascular endothelial growth factor by activation of hypoxia-inducible factor. Transplantation 2008; 85: 1833-40.
47. Bernhardt WM, Gottmann U, Doyon F et al. Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model. Proc. Natl Acad. Sci. USA 2009; 106: 21276-81.
48. Tanaka T, Nangaku M. The role of hypoxia, increased oxygen consumption, and hypoxia-inducible factor-1 alpha in progression of chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 2010; 19: 43-50.
49. G-dimethylarginine dimethylaminohydrolase and protein arginine N-methyltransferase isoforms in diabetic rat kidney: Effects of angiotensin II receptor blockers. Diabetes 2008; 57: 172-80.
50. Welch WJ, Baumgartl H, Lubbers D, Wilcox CS. Renal oxygenation defects in the spontaneously hypertensive rat. Role of AT1 receptors. Kidney Int. 2003; 63: 202-8.
51. Greene AS, Yu ZY, Roman RJ, Cowley AW Jr. Role of blood volume expansion in Dahl rat model of hypertension. Am. J. Physiol. 1990; 258: H508-14.
52. Kawada N, Dennehy K, Solis G et al. TP receptors regulate renal hemodynamics during angiotensin II slow pressor response. Am. J. Physiol. Renal Physiol. 2004; 287: F753-9.
53. Chen Y, Gill PS, Welch WJ. Oxygen availability limits renal NADPH-dependent superoxide production. Am. J. Physiol. Renal Physiol. 2005; 289: F749-53.
54. Weidemann A, Bernhardt WM, Klanke B et al. HIF activation protects from acute kidney injury. J. Am. Soc. Nephrol. 2008; 19: 486-94.
55. Higgins DF, Kimura K, Bernhardt WM et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J. Clin. Invest. 2007; 117: 3810-20.
56. Higgins DF, Kimura K, Iwano M, Haase VH. Hypoxia-inducible factor signaling in the development of tissue fibrosis. Cell Cycle 2008; 7: 1128-32.
57. Rosenberger C, Pratschke J, Rudolph B et al. Immunohistochemical detection of hypoxia-inducible factor-1alpha in human renal allograft biopsies. J. Am. Soc. Nephrol. 2007; 18: 343-51.
58. Wang JJ, Zhang SX, Mott R et al. Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2008; 294: F1166-73.
59. Ng YY, Huang TP, Yang WC et al. Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int. 1998; 54: 864-76.
60. Manotham K, Tanaka T, Matsumoto M et al. Transdifferentiation of cultured tubular cells induced by hypoxia. Kidney Int. 2004; 65: 871-80.
61. Mackensen-Haen S, Bader R, Grund KE, Bohle A. Correlations between renal cortical interstitial fibrosis, atrophy of the proximal tubules and impairment of the glomerular filtration rate. Clin. Nephrol. 1981; 15: 167-71.
62. Krick S, Hanze J, Eul B et al. Hypoxia-driven proliferation of human pulmonary artery fibroblasts: Cross-talk between HIF-1alpha and an autocrine angiotensin system. FASEB J. 2005; 19: 857-9.
63. Rudnicki M, Perco P, Enrich J et al. Hypoxia response and VEGF-A expression in human proximal tubular epithelial cells in stable and progressive renal disease. Lab. Invest. 2009; 89: 337-46.
64. Li N, Chen L, Yi F, Xia M, Li PL. Salt-sensitive hypertension induced by decoy of transcription factor hypoxia-inducible factor-1alpha in the renal medulla. Circ. Res. 2008; 102: 1101-8.
65. Kojima H, Gu H, Nomura S et al. Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1alpha-deficient chimeric mice. Proc. Natl Acad. Sci. USA 2002; 99: 2170-4.
66. Rama I, Bruene B, Torras J et al. Hypoxia stimulus: An adaptive immune response during dendritic cell maturation. Kidney Int. 2008; 73: 816-25.
67. Galindo M, Santiago B, Alcami J, Rivero M, Martin-Serrano J, Pablos JL. Hypoxia induces expression of the chemokines monocyte chemoattractant protein-1 (MCP-1) and IL-8 in human dermal fibroblasts. Clin. Exp. Immunol. 2001; 123: 36-41.
68. Safronova O, Nakahama K, Onodera M, Muneta T, Morita I. Effect of hypoxia on monocyte chemotactic protein-1 (MCP-1) gene expression induced by interleukin-1beta in human synovial fibroblasts. Inflamm. Res. 2003; 52: 480-6.
69. Balsinde J, Winstead MV, Dennis EA. Phospholipase A(2) regulation of arachidonic acid mobilization. FEBS Lett. 2002; 531: 2-6.
70. Nevalainen TJ, Haapamaki MM, Gronroos JM. Roles of secretory phospholipases A(2) in inflammatory diseases and trauma. Biochim. Biophys. Acta 2000; 1488: 83-90.
71. Petry C, Huwiler A, Eberhardt W, Kaszkin M, Pfeilschifter J. Hypoxia increases group IIA phospholipase A(2) expression under inflammatory conditions in rat renal mesangial cells. J. Am. Soc. Nephrol. 2005; 16: 2897-905.
72. Fine LG, Norman JT. Chronic hypoxia as a mechanism of progression of chronic kidney diseases: From hypothesis to novel therapeutics. Kidney Int. 2008; 74: 867-72.